Literature DB >> 31002772

RETRACTED: Ailanthone up-regulates miR-449a to restrain acute myeloid leukemia cells growth, migration and invasion.

Yang Zhang1, Chunzhi Zhang2, Dejin Min3.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments of Dr Elisabeth Bik regarding this article “… the Western blot bands in all 400+ papers are all very regularly spaced and have a smooth appearance in the shape of a dumbbell or tadpole, without any of the usual smudges or stains. All bands are placed on similar looking backgrounds, suggesting they were copy/pasted from other sources, or computer generated”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Acute myeloid leukemia (AML); Ailanthone; Apoptosis; Invasion; Migration; miR-449a

Mesh：

Substances：

Year:  2019        PMID： 31002772     DOI： 10.1016/j.yexmp.2019.04.011

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN： 0014-4800            Impact factor:   3.362


  8 in total

1.  Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

Review 2.  Ailanthone: A novel potential drug for treating human cancer.

Authors:  Haixiang Ding; Xiuchong Yu; Chen Hang; Kaijun Gao; Xifeng Lao; Yangtao Jia; Zhilong Yan
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

Review 3.  Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals.

Authors:  Seung Wan Son; Han Yeoung Lee; Sokviseth Moeng; Hyo Jeong Kuh; Soo Young Choi; Jong Kook Park
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

4.  Ailanthone Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells by Downregulating the Serine Biosynthetic Pathway.

Authors:  Yawen Zhang; Runze Gong; Yong Liu; Xipeng Sun; Jinrong Liang; Yan Zhou; Yaling Wang; Wenxi Yu; Yonggang Wang; Lina Tang; Aina He; Zan Shen; Yang Yao; Haiyan Hu; Xin Liu; Jianjun Zhang
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

Review 5.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 6.  The disruption of protein-protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition.

Authors:  Michael A Serwetnyk; Brian S J Blagg
Journal:  Acta Pharm Sin B       Date:  2020-11-24       Impact factor: 11.413

7.  Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.

Authors:  Lingling Pang; Yun Cheng; Shenchun Zou; Jie Song
Journal:  Thorac Cancer       Date:  2019-12-03       Impact factor: 3.500

8.  Ailanthone suppresses the activity of human colorectal cancer cells through the STAT3 signaling pathway.

Authors:  Haixiang Ding; Xiuchong Yu; Zhilong Yan
Journal:  Int J Mol Med       Date:  2021-12-27       Impact factor: 4.101
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.